View all reports
2019. 03. 06
International symposium - Current status and future role of HTA in Japan and other countries
View all events
2025. 07. 09
New C2H Report: lecanemab (Leqembi)
2025. 05. 14
New C2H Report: Semaglutide (Wegovy)
New C2H Report: Inclisiran (Leqvio)
View all news